Clinical Trial

Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

Name: Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus — clinical trial record (NCT06886126)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

It is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of HDM1005 injection in nondiabetic obese adults.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-03-14; most recent amendment 2025-09-25.

Trial Details

NCT Number	NCT06886126
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Obesity
Enrollment	240 participants
Start Date	2025-02-07
Primary Completion	2025-09-23 (estimated)
Study Completion	2025-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-30